User profiles for David L. Swerdlow
 | David L. Swerdlow, MDHarvard School of Public Health Verified email at hsph.harvard.edu Cited by 38778 |
[HTML][HTML] Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a …
Background Following the emergency use authorisation of the Pfizer–BioNTech mRNA
COVID-19 vaccine BNT162b2 (international non-proprietary name tozinameran) in Israel, the …
COVID-19 vaccine BNT162b2 (international non-proprietary name tozinameran) in Israel, the …
H1N1 2009 influenza virus infection during pregnancy in the USA
…, SA Rasmussen, JL Williams, DL Swerdlow… - The Lancet, 2009 - thelancet.com
Background Pandemic H1N1 2009 influenza virus has been identified as the cause of a
widespread outbreak of febrile respiratory infection in the USA and worldwide. We summarised …
widespread outbreak of febrile respiratory infection in the USA and worldwide. We summarised …
Botulinum toxin as a biological weapon: medical and public health management
…, G Parker, TM Perl, PK Russell, DL Swerdlow… - Jama, 2001 - jamanetwork.com
ObjectiveThe Working Group on Civilian Biodefense has developed consensus-based
recommendations for measures to be taken by medical and public health professionals if …
recommendations for measures to be taken by medical and public health professionals if …
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
…, B Ivanoff, JD Clemens, DL Swerdlow… - Bulletin of the World …, 1999 - ncbi.nlm.nih.gov
Few studies provide data on the global morbidity and mortality caused by infection with Shigella
spp.; such estimates are needed, however, to plan strategies of prevention and treatment…
spp.; such estimates are needed, however, to plan strategies of prevention and treatment…
[HTML][HTML] Epidemiology of Escherichia coli O157: H7 outbreaks, united states, 1982–2002
…, C Crowe, PM Griffin, DL Swerdlow - Emerging infectious …, 2005 - ncbi.nlm.nih.gov
Escherichia coli O157: H7 causes 73,000 illnesses in the United States annually. We reviewed
E. coli O157 outbreaks reported to Centers for Disease Control and Prevention (CDC) to …
E. coli O157 outbreaks reported to Centers for Disease Control and Prevention (CDC) to …
[HTML][HTML] Defining the epidemiology of Covid-19—studies needed
Defining the Epidemiology of Covid-19 Experience with MERS, pandemic influenza, and
other outbreaks has shown that as an epidemic evolves, we face an urgent need to expand …
other outbreaks has shown that as an epidemic evolves, we face an urgent need to expand …
Campylobacter jejuni--an emerging foodborne pathogen.
…, NJ Stern, PI Fields, DL Swerdlow - Emerging infectious …, 1999 - ncbi.nlm.nih.gov
Campylobacter jejuni is the most commonly reported bacterial cause of foodborne infection
in the United States. Adding to the human and economic costs are chronic sequelae …
in the United States. Adding to the human and economic costs are chronic sequelae …
[HTML][HTML] Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings
…, WJ Shieh, L Siegal, DL Swerdlow… - Emerging infectious …, 2002 - ncbi.nlm.nih.gov
In October 2001, the first inhalational anthrax case in the United States since 1976 was
identified in a media company worker in Florida. A national investigation was initiated to identify …
identified in a media company worker in Florida. A national investigation was initiated to identify …
Escherichia coli O157:H7 and the Hemolytic–Uremic Syndrome
TG Boyce, DL Swerdlow, PM Griffin - New England Journal of …, 1995 - Mass Medical Soc
In the decade since its initial description in the Journal, 1 Escherichia coli O157:H7 has
emerged as a major cause of both sporadic cases and outbreaks of diarrhea in North America. …
emerged as a major cause of both sporadic cases and outbreaks of diarrhea in North America. …
Botulism in the United States: a clinical and epidemiologic review
…, C Hatheway, DL Swerdlow - Annals of internal medicine, 1998 - acpjournals.org
Botulism is caused by a neurotoxin produced from the anaerobic, spore-forming bacterium
Clostridium botulinum. Botulism in humans is usually caused by toxin types A, B, and E. Since …
Clostridium botulinum. Botulism in humans is usually caused by toxin types A, B, and E. Since …